News

Company engages respected contractors with Cannabis sector experience to ensure timely acceptance by government agencies VANCOUVER, British Columbia, Nov. 05, 2019 — Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for...

Company aims to develop top regional cannabis brands for entry into EU marketplace VANCOUVER, BC, — October 28, 2019 – Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is pleased to provide an operative overview and update regarding facility development activities in Israel. Concurrent to...

VANCOUVER, British Columbia, Oct. 16, 2019 — Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce the fulfillment of all conditions of its reverse takeover transaction and that the Company has met all conditions to list on the Canadian Securities Exchange. The Company...

VANCOUVER, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) — Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) wishes to advise that further to its news release dated May 21, 2019, the Canadian Securities Exchange (the “CSE”) has conditionally accepted its proposed transaction (the “Transaction”) with Isracann Biosciences Inc. (“Isracann”), which is...

–Related News– Company prepares to service growing European demand for quality high grade products VANCOUVER, British Columbia, May 21, 2019 — Atlas Blockchain Group Inc.  (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) is pleased to announce that it has has closed a second tranche of its recently announced private placement, raising total gross...